Identification of murine cdk10: association with Ets2 transcription factor and effects on the cell cycle

Luigi Bagella1, Cristina Giacinti, Cristiano Simone

  • 1Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, Pennsylvania 19122, USA. bagella@temple.edu

Insights

Murine cdk10, a cell cycle regulator, binds Ets2 transcription factors but does not impact cell proliferation or the G2/M transition, unlike its human counterpart which has multiple isoforms.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Protein Kinases

Background:

  • Cyclin-dependent kinases (cdks) are crucial regulators of the eukaryotic cell cycle, activated by cyclins.
  • Human cdk10 exhibits two isoforms with distinct functions, including roles in cell cycle transition and transcription factor interaction.
  • Cdk10 contains conserved kinase motifs like PSTAIRE-like PISSLRE.

Purpose of the Study:

  • To clone and functionally characterize the murine homologue of cdk10.
  • To investigate the role of murine cdk10 in cell cycle progression and transcription factor binding.

Main Methods:

  • Cloning of murine cdk10 cDNA.
  • In vitro binding assays with Ets2 transcription factors.
  • Analysis of cell proliferation rates and G2/M transition in cell lines expressing murine cdk10.

Main Results:

  • A single murine cdk10 cDNA encoding a 360-amino acid protein was identified, showing high homology to human cdk10.
  • Murine cdk10 demonstrated in vitro binding to Ets2 transcription factors.
  • Murine cdk10 did not exhibit direct involvement in the G2/M transition or affect cell proliferation rates.

Conclusions:

  • Murine cdk10 interacts with Ets2 transcription factors but appears to have a different functional role compared to human isoforms.
  • The unique murine cdk10 does not directly regulate the cell cycle at the G2/M transition or influence cell proliferation.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...